DK155278C - Analogifremgangsmaade til fremstilling af 1-(p-methoxybenzoyl)-2-pyrrolidinon samt 4-(p-methoxybenzoylamino)smoersyre til anvendelse som udgangsmateriale ved denne fremgangsmaade - Google Patents

Analogifremgangsmaade til fremstilling af 1-(p-methoxybenzoyl)-2-pyrrolidinon samt 4-(p-methoxybenzoylamino)smoersyre til anvendelse som udgangsmateriale ved denne fremgangsmaade

Info

Publication number
DK155278C
DK155278C DK056379A DK56379A DK155278C DK 155278 C DK155278 C DK 155278C DK 056379 A DK056379 A DK 056379A DK 56379 A DK56379 A DK 56379A DK 155278 C DK155278 C DK 155278C
Authority
DK
Denmark
Prior art keywords
methoxybenzoylamino
methoxybenzoyl
pyrrolidinone
analogy
procedure
Prior art date
Application number
DK056379A
Other languages
Danish (da)
English (en)
Other versions
DK56379A (da
DK155278B (da
Inventor
Emilio Kyburz
Werner Aschwanden
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK56379A publication Critical patent/DK56379A/da
Publication of DK155278B publication Critical patent/DK155278B/da
Application granted granted Critical
Publication of DK155278C publication Critical patent/DK155278C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK056379A 1978-02-10 1979-02-09 Analogifremgangsmaade til fremstilling af 1-(p-methoxybenzoyl)-2-pyrrolidinon samt 4-(p-methoxybenzoylamino)smoersyre til anvendelse som udgangsmateriale ved denne fremgangsmaade DK155278C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH140378 1978-02-10
CH140378 1978-02-10
CH1198178 1978-11-22
CH1198178 1978-11-22

Publications (3)

Publication Number Publication Date
DK56379A DK56379A (da) 1979-08-11
DK155278B DK155278B (da) 1989-03-20
DK155278C true DK155278C (da) 1989-07-24

Family

ID=25687541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK056379A DK155278C (da) 1978-02-10 1979-02-09 Analogifremgangsmaade til fremstilling af 1-(p-methoxybenzoyl)-2-pyrrolidinon samt 4-(p-methoxybenzoylamino)smoersyre til anvendelse som udgangsmateriale ved denne fremgangsmaade

Country Status (34)

Country Link
US (1) US4369139A (ru)
EP (2) EP0044088B1 (ru)
JP (1) JPS6059907B2 (ru)
AR (1) AR220739A1 (ru)
AT (1) AT374787B (ru)
AU (1) AU525514B2 (ru)
BG (1) BG29281A3 (ru)
BR (1) BR7900684A (ru)
CA (1) CA1100515A (ru)
CS (1) CS226182B2 (ru)
CU (1) CU21107A3 (ru)
DD (1) DD141828A5 (ru)
DE (1) DE2963321D1 (ru)
DK (1) DK155278C (ru)
EG (1) EG13873A (ru)
ES (2) ES477587A1 (ru)
FI (1) FI69063C (ru)
GR (1) GR71464B (ru)
HK (1) HK6185A (ru)
HU (1) HU177644B (ru)
IE (1) IE47831B1 (ru)
IL (1) IL56587A0 (ru)
IN (1) IN150106B (ru)
MC (1) MC1257A1 (ru)
MY (1) MY8500340A (ru)
NO (1) NO152046C (ru)
NZ (1) NZ189571A (ru)
OA (1) OA06180A (ru)
PH (1) PH15491A (ru)
PL (1) PL115958B1 (ru)
PT (1) PT69206A (ru)
RO (1) RO76615A (ru)
SU (1) SU931104A3 (ru)
YU (1) YU41330B (ru)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8004025A (nl) * 1979-08-09 1981-02-11 Hoffmann La Roche Pyrrolidinederivaten en werkwijze voor het bereiden daarvan alsmede geneesmiddel.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4398938A (en) * 1982-05-20 1983-08-16 Velsicol Chemical Corporation N-Acylated lactams and their herbicidal compositions and method of use
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
CH661174GA3 (ru) * 1985-07-10 1987-07-15
US4691853A (en) * 1985-12-30 1987-09-08 Technalytics, Inc. Surgical stapler
US5300642A (en) * 1986-04-10 1994-04-05 The Du Pont Merck Pharmaceutical Company α, α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
US5202345A (en) * 1987-08-19 1993-04-13 Shionogi & Co., Ltd. Carbamoylpyrrolidone derivatives and drugs for senile dementia
CA1305148C (en) * 1987-08-19 1992-07-14 Hiromu Matsumura Carbamoylpyrrolidone derivatives and drugs for senile dementia
JP2585086B2 (ja) * 1988-12-28 1997-02-26 大鵬薬品工業株式会社 ジアザビシクロアルカン誘導体
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 1―フエノキシカルボニル―2―ピロリジノン誘導体
JP3038032B2 (ja) * 1991-03-25 2000-05-08 日清製粉株式会社 血小板凝集抑制薬
ATE253909T1 (de) * 1992-07-24 2003-11-15 Univ California Arzneimittel die den durch ampa rezeptoren vermittelten synaptischen response erhöhen
US5852008A (en) * 1995-01-24 1998-12-22 The Regents Of The University Of California Heteroatom substituted benzoyl derivatives that enhance synaptic response mediated by receptors
CA2212829A1 (en) * 1995-02-21 1996-08-29 Jiro Takeo Glutamic acid receptor agonist
FR2792833B1 (fr) * 1999-04-27 2002-09-06 Hoffmann La Roche Utilisation de l'acide n-anisoyl-gamma-aminobutyrique ou de l'acide p-anisique pour la preparation d'une composition pharmaceutique
US7608636B2 (en) 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
US8858594B2 (en) * 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
EP2604592B1 (en) 2011-12-12 2014-10-08 Zaklady Farmaceutyczne Polpharma SA A process for the purification of aniracetam by crystallisation from aqueous solutions
CN109651222A (zh) * 2018-12-21 2019-04-19 上海昊航化工有限公司 一种阿尼西坦的催化合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
DE2413935A1 (de) * 1974-03-20 1975-10-16 Schering Ag 4-(polyalkoxy-phenyl)-2-pyrrolidone
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.

Also Published As

Publication number Publication date
HK6185A (en) 1985-02-01
DK56379A (da) 1979-08-11
YU41330B (en) 1987-02-28
AU4391679A (en) 1979-08-16
EP0005143B1 (de) 1982-07-14
FI69063B (fi) 1985-08-30
EP0044088A2 (de) 1982-01-20
GR71464B (ru) 1983-05-30
PL213340A1 (ru) 1980-03-24
YU28379A (en) 1983-02-28
MC1257A1 (fr) 1980-01-14
IL56587A0 (en) 1979-05-31
JPS54117468A (en) 1979-09-12
CU21107A3 (es) 1988-02-01
AU525514B2 (en) 1982-11-11
OA06180A (fr) 1981-06-30
NO152046C (no) 1985-07-24
ATA99579A (de) 1983-10-15
BR7900684A (pt) 1979-09-04
SU931104A3 (ru) 1982-05-23
NZ189571A (en) 1984-07-06
AT374787B (de) 1984-05-25
RO76615A (ro) 1981-04-30
PH15491A (en) 1983-01-31
EG13873A (en) 1982-12-31
IE790246L (en) 1979-08-20
ES483756A1 (es) 1980-04-16
EP0044088B1 (de) 1984-02-22
IN150106B (ru) 1982-07-24
DE2963321D1 (en) 1982-09-02
PT69206A (en) 1979-03-01
US4369139A (en) 1983-01-18
JPS6059907B2 (ja) 1985-12-27
FI69063C (fi) 1985-12-10
EP0005143A1 (de) 1979-11-14
IE47831B1 (en) 1984-06-27
NO152046B (no) 1985-04-15
ES477587A1 (es) 1980-01-16
EP0044088A3 (en) 1982-02-03
HU177644B (en) 1981-11-28
DD141828A5 (de) 1980-05-21
CS226182B2 (en) 1984-03-19
MY8500340A (en) 1985-12-31
NO790434L (no) 1979-08-13
FI790226A (fi) 1979-08-11
AR220739A1 (es) 1980-11-28
CA1100515A (en) 1981-05-05
DK155278B (da) 1989-03-20
BG29281A3 (en) 1980-10-15
PL115958B1 (en) 1981-05-30

Similar Documents

Publication Publication Date Title
DK155278C (da) Analogifremgangsmaade til fremstilling af 1-(p-methoxybenzoyl)-2-pyrrolidinon samt 4-(p-methoxybenzoylamino)smoersyre til anvendelse som udgangsmateriale ved denne fremgangsmaade
DK158346C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-alkylsulfonyl-o-anisamid-derivater samt 2-methoxy-4-amino-5-alkylsulfonylbenzoesyrer til anvendelse som mellemprodukter ved fremgangsmaaden
DK159808C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til anvendelse ved behandling af osteitis
DK150784C (da) Fremgangsmaade til fremstilling af kugleformede produkter i fast tilstandsform ved stuetemperatur
DK223379A (da) Fremgangsmaade ved bestemmelse af overensstemmelsesgraden mellem to datasamlinger samt databehandlingsorganer til udoevelse af fremgangsmaaden
DK400281A (da) Sammensatte materialer til selektiv tilbageholdelse af kemiske arter fremgangsmaade til deres fremstilling samt deres anvendelse
DK479879A (da) Fodtoej samt fremgangsmaade til dets fremstilling
DK224480A (da) 2-phenyl-alken-1-yl-cyclopropancarboxylsyreestere deres fremstilling og anvendelse som insecticider og acaricider samt mellemprodukter til brug ved fremstillingen
DK156657C (da) Fremgangsmaade til fremstilling af azolyl-vinyl-ketoner samt ketoenaminer til anvendelse som mellemprodukter ved fremgangsmaaden
DK157024C (da) Analogifremgangsmaade til fremstilling af 4-substituerede imidazooe1,2-aaaquinoxaliner samt 1-(2-acylaminophenyl)imidazoler til anvendelse som udgangsmaterialer ved fremgangsmaaden
FI790019A (fi) Foerfarande foer framstaellning av 4-(61-metoxi-21-naftyl)butan-2-on med antiinflammatorisk aktivitet
DK157538C (da) Analogifremgangsmaade til fremstilling af heterocycliske phenoxyaminer samt 1-cyclohexenylmethyl-pyrrolidiner til anvendelse som mellemprodukt ved fremgangsmaaden
DK138481A (da) Stopper til line fremgangsmaade til fremstilling af stopperen samt anvendelse af samme
DK161521C (da) Fremgangsmaade til fremstilling af cephalosporiner samt thiestere til anvendelse som udgangsmateriale ved fremgangsmaaden
DK157020C (da) Analogifremgangsmaade til fremstilling phenylaminothiopheneddikesyreforbindelser samt funktionelle phenylaminothiopheneddikesyrederivater til anvendelse som udgangsmaterialer ved denne fremgangsmaade
DK394480A (da) Fremgangsmaade til fremstilling af 1-azolyl-1-phenoxy-alkan-2-oner samt ved fremstillingen anvendte mellemprodukter
DK223783D0 (da) Fremgangsmade til fremstilling af dihydropyridiner samt mellemprodukter til anvendelse ved fremgangsmaden
DK153579A (da) Fremgangsmaade til fremstilling af derivater af pyrrolidincarboxaldehyd og piperidincarboxaldehyd samt mellemprodukter hertil
NO793897L (no) Fremgangsmaate ved dealkylering av alkylfenoler.
DK154021C (da) Analogifremgangsmaade til fremstilling af phenoxy-aminopropanolderivater og epoxider til anvendelse som udgangsmateriale ved denne fremgangsmaade
DK575678A (da) 5-(2-anilinoalkylamino-1-hydroxyalkyl) salicylamider fremgangsmaade til deres fremstilling samt farmaceutiske kompositioner indeholdende disse
DK288381A (da) Anordning til forhindring af sedimentaflejringer i fordamperes stigroer
DK164324C (da) 11beta-substituerede 5-hydroxy-9-en-steroidforbindelser til anvendelse som udgangsmaterialer ved fremstilling af 11beta-substituerede 4,9-diensteroidforbindelser samt fremgangsmaade til fremstilling af disse udgangsmaterialer
DK336379A (da) Fremgangsmaade til fremstilling af benzodiazepinderivater samt mellemprodukter til anvendelse ved fremgangsmaaden
DK49579A (da) Fremgangsmaade til fremstilling af alkyl 2-arylacyrlater samt ved fremgangsmaaden

Legal Events

Date Code Title Description
ATS Application withdrawn